Dr. Reddy's Launches Toripalimab, Breakthrough Cancer Drug, in India Nov. 28, 2024, 12:18 p.m. Dr. Reddy's Laboratories has launched Toripalimab in India, a new immuno-oncology drug for treating nasopharyngeal carcinoma (NPC).Toripalimab is the only drug of its kind approved b… Unlock the Full Filing And Lot More Access premium insights and stay ahead of the market with Dzambhala Pro. Learn More